The purpose of this document is to give guidance to Receiving Authorities on the evaluation of the GLP compliance status of nonclinical safety studies submitted for regulatory purposes. This guidance does not address the scientific evaluation and interpretation of the submitted data or the risk assessment based on these data.
Guidance for Receiving Authorities on the Review of the GLP Status of Non‑Clinical Safety Studies
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
2 December 202413 Pages
-
18 July 202215 Pages
-
7 May 202014 Pages
-
19 April 201820 Pages
-
Report9 February 201612 Pages
Related publications
-
2 July 2026115 Pages
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
2 July 202663 Pages -
Report
Assays addressing the Adverse Outcome Pathway Key Event on Keratinocyte activation
2 July 202698 Pages